FinnCap reaffirmed their buy rating on shares of Abzena PLC (LON:ABZA) in a report issued on Wednesday morning, reports. FinnCap currently has a GBX 80 ($1.03) price objective on the stock.

Separately, Numis Securities Ltd restated a buy rating and set a GBX 93 ($1.20) price objective on shares of Abzena PLC in a research report on Friday, May 26th.

Shares of Abzena PLC (ABZA) opened at 45.50 on Wednesday. The stock’s 50 day moving average is GBX 47.49 and its 200-day moving average is GBX 40.90. Abzena PLC has a 52-week low of GBX 31.00 and a 52-week high of GBX 66.00. The firm’s market cap is GBX 62.72 million.

COPYRIGHT VIOLATION WARNING: “Abzena PLC’s (ABZA) Buy Rating Reiterated at FinnCap” was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at

About Abzena PLC

Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.

Stock Target Prices

Receive News & Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.